New fast-track route could shave years off the time it takes for people with Parkinson's to benefit from new and better treatments.
UK researchers have shared promising results of a phase 2 clinical trial of the type 2 diabetes drug exenatide in people with Parkinson's.
New research, reported in the scientific journal Nature, suggests that the immune system plays an important role in the progression of Parkinson's.
Higher consumption of low fat dairy products such as milk, butter, cheese and yoghurt is linked to a modest increase in risk of Parkinson’s, according to new research.
The groundbreaking clinical trial of GDNF, a potential treatment for Parkinson's, is now complete. Analysis of the results is now well underway and is expected to be published in the summer.